Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
194.19 USD | -0.08% | -0.05% | +25.31% |
Oct. 10 | Truist Securities Adjusts AbbVie Price Target to $215 From $210 | MT |
Oct. 09 | UBS Adjusts Price Target on AbbVie to $195 From $185, Maintains Neutral Rating | MT |
Chart calendar AbbVie Inc.
Upcoming events on AbbVie Inc.
Past events on AbbVie Inc.
2024-07-25 09:00 am | Q2 2024 Earnings Call |
2024-07-25 07:36 am | Q2 2024 Earnings Release |
2024-07-14 | Détachement de |
2024-06-12 10:00 am | Goldman Sachs Global Healthcare Conference |
2024-06-03 03:15 pm | American Society of Clinical Oncology Meeting - Abstract No: 3515 |
2024-06-02 11:01 am | American Society of Clinical Oncology Meeting - Abstract No: 103 |
2024-06-01 04:12 pm | American Society of Clinical Oncology Meeting - Abstract No: 3001 |
2024-05-15 01:40 pm | BofA Securities Health Care Conference |
2024-05-03 10:00 am | Annual General Meeting |
2024-04-26 09:00 am | Q1 2024 Earnings Call |
2024-04-26 07:35 am | Q1 2024 Earnings Release |
2024-04-11 | Détachement de |
2024-03-27 11:30 am | Anti-Aging and Aesthetics Medicine World Congress |
2024-03-27 09:00 am | Anti-Aging and Aesthetics Medicine World Congress |
2024-03-27 06:15 am | Anti-Aging and Aesthetics Medicine World Congress |
2024-03-27 04:45 am | Anti-Aging and Aesthetics Medicine World Congress |
2024-03-14 09:00 am | Barclays Global Healthcare Conference |
2024-03-10 05:45 pm | American Academy of Dermatology Meeting |
2024-03-10 05:40 pm | American Academy of Dermatology Meeting |
2024-03-10 05:30 pm | American Academy of Dermatology Meeting |
Past dividends on AbbVie Inc.
2024-07-14 | Quarterly 1.55 USD |
2024-04-11 | Quarterly 1.55 USD |
2024-01-11 | Quarterly 1.55 USD |
2023-10-11 | Quarterly 1.48 USD |
2023-07-12 | Quarterly 1.48 USD |
2023-04-12 | Quarterly 1.48 USD |
2023-01-11 | Quarterly 1.48 USD |
2022-10-12 | Quarterly 1.41 USD |
2022-07-13 | Quarterly 1.41 USD |
2022-04-12 | Quarterly 1.41 USD |
2022-01-12 | Quarterly 1.41 USD |
2021-10-13 | Quarterly 1.3 USD |
2021-07-13 | Quarterly 1.3 USD |
2021-04-13 | Quarterly 1.3 USD |
2021-01-13 | Quarterly 1.3 USD |
2020-10-13 | Quarterly 1.18 USD |
2020-07-13 | Quarterly 1.18 USD |
2020-04-13 | Quarterly 1.18 USD |
2020-01-13 | Quarterly 1.18 USD |
2019-10-10 | Quarterly 1.07 USD |
Annual results
Fiscal Period | Dezember | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 56 122 56 238 -0.21% | 58 054 58 284 -0.4% | 54 318 54 047 0.5% | 55 700 | 58 598 | 62 696 |
EBITDA Million USD | Released Forecast Spread | 29 018 29 168 -0.51% | 30 961 31 181 -0.7% | 25 545 25 858 -1.21% | 25 749 | 28 498 | 31 238 |
EBIT Million USD | Released Forecast Spread | 28 215 28 167 0.17% | 30 183 30 154 0.1% | 24 793 24 926 -0.53% | 24 836 | 27 637 | 30 460 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 12 989 12 579 3.26% | 13 477 16 796 -19.76% | 6 250 8 933 -30.04% | 11 178 | 14 880 | 16 712 |
Net income Million USD | Released Forecast Spread | 11 542 11 140 3.61% | 11 836 14 494 -18.34% | 4 863 8 288 -41.32% | 8 495 | 11 734 | 14 289 |
EPS USD | Released Forecast Spread | 6,45 6,25 3.27% | 6,63 8,28 -19.89% | 2,72 5,30 -48.69% | 5,24 | 7,22 | 8,77 |
Announcement Date | 02/02/22 | 09/02/23 | 02/02/24 | - |
Quarterly results
Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 14 812 14 944 -0.89% | 15 121 15 337 -1.41% | 12 225 12 230 -0.04% | 13 865 13 520 2.55% | 13 927 13 707 1.6% | 14 301 14 027 1.96% | 12 310 11 936 3.14% | 14 462 14 027 3.1% | 14 264 | 14 649 | 13 183 | 14 448 | 14 887 | 15 569 |
EBITDA Million USD | Released Forecast Spread | 8 090 8 645 -6.42% | 8 072 8 405 -3.96% | 5 682 5 686 -0.06% | 6 710 6 633 1.16% | 6 706 6 681 0.37% | 6 447 6 600 -2.32% | 5 378 5 444 -1.21% | 6 342 6 781 -6.47% | 6 847 | 6 979 | 6 037 | 7 276 | 7 143 | 7 246 |
EBIT Million USD | Released Forecast Spread | 7 909 7 843 0.85% | 7 876 7 778 1.26% | 5 503 5 553 -0.9% | 6 520 6 398 1.9% | 6 510 6 498 0.19% | 6 260 6 391 -2.05% | 5 195 5 158 0.71% | 6 158 6 229 -1.14% | 6 690 | 6 752 | 6 217 | 7 045 | 7 096 | 7 311 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 475 5 059 -90.61% | 2 610 3 685 -29.17% | 1 953 3 960 -50.68% | 1 212 3 839 -68.43% | 1 755 2 367 -25.86% | 2 146 3 226 -33.48% | 3 385 | 3 393 | ||||||
Net income Million USD | Released Forecast Spread | 3 949 5 207 -24.16% | 2 473 3 781 -34.59% | 239 2 405 -90.06% | 2 024 2 570 -21.25% | 1 778 2 937 -39.46% | 822 1 580 -47.98% | 1 369 1 220 12.17% | 1 370 1 912 -28.35% | 2 284 | 2 500 | 1 818 | 2 169 | 2 368 | 2 651 |
EPS USD | Released Forecast Spread | 2,21 2,87 -22.91% | 1,38 2,71 -49.14% | 0,13 1,42 -90.82% | 1,14 1,43 -20.46% | 1,00 1,72 -41.86% | 0,46 2,00 -76.95% | 0,77 0,66 16.08% | 0,77 1,49 -48.21% | 1,48 | 1,43 | 1,02 | 1,22 | 1,34 | 1,50 |
Announcement Date | 28/10/22 | 09/02/23 | 27/04/23 | 27/07/23 | 27/10/23 | 02/02/24 | 26/04/24 | 25/07/24 | - | - | - | - | - | - |
Past sector events for AbbVie Inc.
2024-10-10 07:00 am | TILRAY BRANDS, INC.: Q1 2025 Earnings Release |
2024-10-10 01:00 am | FAGRON N.V.: Q3 2024 Sales and Revenue Release - Trading Update |
2024-10-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q2 2025 Earnings Release |
2024-10-09 | HISAMITSU PHARMACEUTICAL CO., INC.: Q2 2024 Earnings Release |
2024-10-09 04:59 am | SCINOPHARM TAIWAN, LTD.: September 2024 Sales and Revenue Release |
2024-10-08 04:12 am | CALIWAY BIOPHARMACEUTICALS CO., LTD.: September 2024 Sales and Revenue Release |
2024-10-08 03:30 am | BORA PHARMACEUTICALS CO., LTD.: September 2024 Sales and Revenue Release |
2024-10-04 05:26 am | ONENESS BIOTECH CO., LTD.: September 2024 Sales and Revenue Release |
2024-09-30 04:55 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q2 2024 Earnings Release |
2024-09-10 04:14 am | LOTUS PHARMACEUTICAL CO., LTD.: August 2024 Sales and Revenue Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABBV Stock
- Calendar AbbVie Inc.